Drugs / AlloDerm
AlloDerm
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03057730 | Aug 2015 → Sep 2025 overdue | gingival recession | Tufts University | Active not recruiting | No outcome recorded |
| Phase 4 | NCT02450383 | Jan 2015 → Sep 2016 | periodontal disorder, tooth disorder | University of Iowa | Completed | No outcome recorded |
Also used as a comparator or background therapy in 7 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT06241196 Comparator | Jul 2022 → Apr 2024 | — | Tanta University | Unknown | No outcome recorded |
| Phase 2 | NCT01834339 Comparator | Sep 2013 → Nov 2014 | — | Stephen E. Feinberg | Terminated | No outcome recorded |
| Phase 2 | NCT02135471 Background | Jun 2009 → Nov 2011 | gingival recession | University of Sao Paulo | Completed | No outcome recorded |
| Phase 44 trials | ||||||
| Phase 4 | NCT07203326 Comparator | Feb 2025 → Aug 2026 overdue | gingival recession | Ohio State University | Active not recruiting | No outcome recorded |
| Phase 4 | NCT05565079 Background | Oct 2022 → Oct 2024 | gingival recession | University of Louisville | Completed | No outcome recorded |
| Phase 4 | NCT04614350 Comparator | Oct 2020 → Feb 2022 | gingival recession | McGuire Institute | Completed | No outcome recorded |
| Phase 4 | NCT02372305 Comparator | Mar 2016 → Dec 2017 | breast neoplasm | University of Arkansas | Withdrawn | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AlloDerm | “24 patients will be treated with a coronally positioned tunnel with AlloDerm RTM with or without the addition of Enamel Matrix Derivative to compare the baseline and 6-month...” NCT05565079 ↗ |
| Known as | Acellular Dermal Matrix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03057730 ↗ |
| Known as | acellular dermal matrix graft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02135471 ↗ |
| Modality | Other / unclassified | “ADM is a human-derived allograft material, treated to remove all cellular components so that only the connective tissue matrix remains.” NCT03057730 ↗ |
| Route | Other | “The ADM will be placed beneath the flap.” NCT03057730 ↗ |